XML 28 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity (Tables)
9 Months Ended
Dec. 31, 2022
Class Of Stock [Line Items]  
Schedule of Stock-based Compensation Expense

Stock-based compensation expense for all stock-based awards consists of the following (in thousands):

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

December 31, 2022

 

 

December 31, 2021

 

 

December 31, 2022

 

 

December 31, 2021

 

Research and development

 

$

117

 

 

$

111

 

 

$

363

 

 

$

267

 

General and administrative

 

$

427

 

 

$

477

 

 

$

1,514

 

 

$

1,162

 

Total

 

$

544

 

 

$

588

 

 

$

1,877

 

 

$

1,429

 

Fair Value of Employee Stock Options The fair value of stock options was estimated at the grant date using the following weighted average assumptions:

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

December 31, 2022

 

 

December 31, 2021

 

 

December 31, 2022

 

 

December 31, 2021

 

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

95.93

%

 

 

95.42

%

 

 

95.43

%

 

 

95.96

%

Risk-free interest rate

 

 

3.97

%

 

 

1.20

%

 

 

3.21

%

 

 

1.19

%

Expected life of options

 

6.00 years

 

 

5.69 years

 

 

6.00 years

 

 

5.70 years

 

Weighted average grant
   date fair value

 

$

1.23

 

 

$

5.20

 

 

$

1.96

 

 

$

5.23

 

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity from March 31, 2022 to December 31, 2022:

 

 

 

Options
Outstanding

 

 

Weighted
Average
Exercise Price

 

 

Aggregate
Intrinsic
Value

 

Outstanding at March 31, 2022

 

 

1,203,671

 

 

$

7.36

 

 

$

71,650

 

Options granted

 

 

209,474

 

 

$

2.51

 

 

$

 

Options cancelled / forfeited

 

 

(6,092

)

 

$

5.38

 

 

$

 

Options exercised

 

 

 

 

$

 

 

$

 

Outstanding at December 31, 2022

 

 

1,407,053

 

 

$

6.65

 

 

$

 

Vested and Exercisable at December 31, 2022

 

 

487,477

 

 

$

7.28

 

 

$

 

Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consisted of the following at December 31, 2022:

 

Common stock issuable pursuant to options outstanding and reserved under the 2012 Plan

 

 

1,347,500

 

Common stock reserved under the 2012 Plan

 

 

 

Common stock issuable pursuant to options outstanding and reserved under the 2022 Plan

 

 

9,553

 

Common stock reserved under the 2022 Plan

 

 

1,115,635

 

Common stock reserved under the ESPP

 

 

59,435

 

Common stock reserved under the 2021 Inducement Equity Plan

 

 

1,000

 

Common stock issuable pursuant to restricted stock units outstanding under the 2012 Plan

 

 

11,416

 

Common stock issuable pursuant to restricted stock units outstanding under the 2022 Plan

 

 

117,642

 

Common stock issuable pursuant to options outstanding and reserved under the Inducement Plan

 

 

50,000

 

Total at December 31, 2022

 

 

2,712,181

 

Restricted stock units (RSUs) [Member]  
Class Of Stock [Line Items]  
Summary of Company's RSUs Activity and Performance-Based RSUs Activity

The following table summarizes the Company’s RSUs (not including performance-based RSUs) activity from March 31, 2022 through December 31, 2022:

 

 

Number of
Shares

 

 

Weighted
Average Price

 

Unvested at March 31, 2022

 

 

15,500

 

 

$

10.58

 

Granted

 

 

117,642

 

 

$

1.53

 

Vested

 

 

(4,084

)

 

$

11.06

 

Cancelled / forfeited

 

 

 

 

$

 

Unvested at December 31, 2022

 

 

129,058

 

 

$

2.32

 

ESPP Shares [Member]  
Class Of Stock [Line Items]  
Fair Value of Employee Stock Options The fair value of ESPP shares was estimated at the purchase period commencement date using the following assumptions:

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

 

December 31, 2022

 

 

December 31, 2021*

 

 

December 31, 2022

 

 

December 31, 2021*

 

 

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

0.00

%

 

 

0.00

%

 

 

86.58

%

 

 

0.00

%

 

Risk-free interest rate

 

 

0.00

%

 

 

0.00

%

 

 

3.34

%

 

 

0.00

%

 

Expected term

 

 

 

 

 

 

 

6 months

 

 

 

 

 

Grant date fair value

 

$

 

 

$

 

 

$

0.82

 

 

$